S&P 500   3,091.88 (+0.00%)
DOW   27,769.68 (+0.28%)
QQQ   201.21 (-0.16%)
CGC   18.44 (-4.21%)
BABA   181.95 (-2.68%)
GE   11.26 (-1.40%)
T   39.15 (-0.05%)
F   8.82 (-2.43%)
ACB   3.56 (-0.28%)
DIS   148.80 (+7.37%)
S&P 500   3,091.88 (+0.00%)
DOW   27,769.68 (+0.28%)
QQQ   201.21 (-0.16%)
CGC   18.44 (-4.21%)
BABA   181.95 (-2.68%)
GE   11.26 (-1.40%)
T   39.15 (-0.05%)
F   8.82 (-2.43%)
ACB   3.56 (-0.28%)
DIS   148.80 (+7.37%)
S&P 500   3,091.88 (+0.00%)
DOW   27,769.68 (+0.28%)
QQQ   201.21 (-0.16%)
CGC   18.44 (-4.21%)
BABA   181.95 (-2.68%)
GE   11.26 (-1.40%)
T   39.15 (-0.05%)
F   8.82 (-2.43%)
ACB   3.56 (-0.28%)
DIS   148.80 (+7.37%)
S&P 500   3,091.88 (+0.00%)
DOW   27,769.68 (+0.28%)
QQQ   201.21 (-0.16%)
CGC   18.44 (-4.21%)
BABA   181.95 (-2.68%)
GE   11.26 (-1.40%)
T   39.15 (-0.05%)
F   8.82 (-2.43%)
ACB   3.56 (-0.28%)
DIS   148.80 (+7.37%)
Log in

Avinger Stock Price, Forecast & Analysis (NASDAQ:AVGR)

$0.97
-0.01 (-1.02 %)
(As of 11/13/2019 03:56 PM ET)
Today's Range
$0.95
Now: $0.97
$1.02
50-Day Range
$0.78
MA: $1.01
$1.43
52-Week Range
$0.77
Now: $0.97
$12.60
Volume4,722 shs
Average Volume425,610 shs
Market Capitalization$6.23 million
P/E RatioN/A
Dividend YieldN/A
Beta1.66
Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AVGR
CUSIPN/A
Phone650-241-7900

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$7.91 million
Book Value$2.71 per share

Profitability

Net Income$-27,560,000.00
Net Margins-237.51%

Miscellaneous

EmployeesN/A
Market Cap$6.23 million
Next Earnings Date3/4/2020 (Estimated)
OptionableNot Optionable

Receive AVGR News and Ratings via Email

Sign-up to receive the latest news and ratings for AVGR and its competitors with MarketBeat's FREE daily newsletter.


Avinger (NASDAQ:AVGR) Frequently Asked Questions

What is Avinger's stock symbol?

Avinger trades on the NASDAQ under the ticker symbol "AVGR."

When did Avinger's stock split? How did Avinger's stock split work?

Avinger's stock reverse split before market open on Wednesday, January 31st 2018. The 1-40 reverse split was announced on Tuesday, January 30th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, January 30th 2018. An investor that had 100 shares of Avinger stock prior to the reverse split would have 3 shares after the split.

How were Avinger's earnings last quarter?

Avinger Inc (NASDAQ:AVGR) announced its earnings results on Tuesday, November, 5th. The medical device company reported ($0.70) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.60) by $0.10. The medical device company earned $2.41 million during the quarter. Avinger had a negative net margin of 237.51% and a negative return on equity of 197.22%. View Avinger's Earnings History.

When is Avinger's next earnings date?

Avinger is scheduled to release their next quarterly earnings announcement on Wednesday, March 4th 2020. View Earnings Estimates for Avinger.

What is the consensus analysts' recommendation for Avinger?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avinger in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Avinger.

Has Avinger been receiving favorable news coverage?

Media headlines about AVGR stock have been trending very negative on Wednesday, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Avinger earned a coverage optimism score of -3.2 on InfoTrie's scale. They also gave media stories about the medical device company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the company's share price in the near term. View News Stories for Avinger.

Are investors shorting Avinger?

Avinger saw a decline in short interest in October. As of October 31st, there was short interest totalling 63,200 shares, a decline of 79.0% from the September 30th total of 300,800 shares. Based on an average trading volume of 423,200 shares, the days-to-cover ratio is presently 0.1 days. Approximately 1.0% of the shares of the company are short sold. View Avinger's Current Options Chain.

Who are some of Avinger's key competitors?

What other stocks do shareholders of Avinger own?

Who are Avinger's key executives?

Avinger's management team includes the folowing people:
  • Mr. Jeffrey M. Soinski, Pres, CEO & Director (Age 57)
  • Mr. Mark B. Weinswig, Chief Financial Officer (Age 46)
  • Mr. Himanshu N. Patel, Chief Technology Officer (Age 59)
  • Mr. Keith Schaefer, Chief Operating Officer
  • Mr. Philip R. Preuss, VP of Marketing & Bus. Operations (Age 41)

When did Avinger IPO?

(AVGR) raised $60 million in an initial public offering on Friday, January 30th 2015. The company issued 4,600,000 shares at $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company served as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers.

Who are Avinger's major shareholders?

Avinger's stock is owned by a number of of retail and institutional investors. Top institutional investors include Perkins Capital Management Inc. (12.36%) and Wedbush Securities Inc. (1.18%). Company insiders that own Avinger stock include Himanshu Patel and John B Ph D Md Simpson. View Institutional Ownership Trends for Avinger.

Which institutional investors are buying Avinger stock?

AVGR stock was acquired by a variety of institutional investors in the last quarter, including Perkins Capital Management Inc. and Wedbush Securities Inc.. View Insider Buying and Selling for Avinger.

How do I buy shares of Avinger?

Shares of AVGR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Avinger's stock price today?

One share of AVGR stock can currently be purchased for approximately $0.97.

How big of a company is Avinger?

Avinger has a market capitalization of $6.23 million and generates $7.91 million in revenue each year. The medical device company earns $-27,560,000.00 in net income (profit) each year or ($33.40) on an earnings per share basis. View Additional Information About Avinger.

What is Avinger's official website?

The official website for Avinger is http://www.avinger.com/.

How can I contact Avinger?

Avinger's mailing address is 400 CHESAPEAKE DRIVE, REDWOOD CITY CA, 94063. The medical device company can be reached via phone at 650-241-7900 or via email at [email protected]


MarketBeat Community Rating for Avinger (NASDAQ AVGR)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  315 (Vote Outperform)
Underperform Votes:  275 (Vote Underperform)
Total Votes:  590
MarketBeat's community ratings are surveys of what our community members think about Avinger and other stocks. Vote "Outperform" if you believe AVGR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AVGR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/13/2019 by MarketBeat.com Staff

Featured Article: What is range trading?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel